Martin Tami Tillotson
- SEC CIK
- 0001539494
No open-market purchases or sales filed in the past year.
Current role at each company
- SUPN Supernus Pharmaceuticals, Inc.Sr. V.P., Regulatory Affairsas of Feb 27, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Martin Tami Tillotson as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 (view filing) | Jan 10 | 2 days | Martin Tami TillotsonSr. V.P., Regulatory Affairs | SSale | −8.00K | $27.91 | −$223.3K | −8.5%85.7K after | 10b5-1 |
| Sep 1, 2023 (view filing) | Aug 30 | 2 days | Martin Tami TillotsonSr. V.P., Regulatory Affairs | SSale | −8.10K | $32.00 | −$259.2K | −8.7%85.2K after | |
| Aug 29, 2023 (view filing) | Aug 25 | 4 days | Martin Tami TillotsonSr. V.P., Regulatory Affairs | SSale | −5.13K | $31.59 | −$162.2K | −5.7%85.2K after | |
| Aug 23, 2022 (view filing) | Aug 22 | 1 day | Martin Tami TillotsonSr. V.P., Regulatory Affairs | SSale | −5.00K | $35.98 | −$179.9K | −5.4%87.2K after | |
| Aug 5, 2022 (view filing) | Aug 4 | 1 day | Martin Tami TillotsonSr. V.P., Regulatory Affairs | SSale | −5.00K | $32.98 | −$164.9K | −5.4%87.2K after |